Mitochondria restructuring protein provides new therapeutic target for heart disease

Hyungsoo Kim, Ph.D. is a postdoctoral researcher and first author of the study. Credit: Sanford-Burnham Medical Research Institute

Mitochondria are often called cellular "powerhouses" because they convert nutrients into energy. But these tiny structures also help determine cellular lifespan. Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) are now discovering how mitochondria alternate between duplicating and fragmenting and how these events help cells adapt to diverse physiological conditions.

In a paper published November 18 in Molecular Cell, a team led by Ze'ev Ronai, Ph.D. discovered that the protein Siah2 regulates mitochondrial fragmentation under low oxygen conditions. The significance of these findings is demonstrated by the heart's response to oxygen shortage and ischemia, the caused by , when the researchers inhibited Siah2. In cells and mice lacking the protein, heart cell death was prevented. As a result, tissue damage was reduced in a that mimics a heart attack.

"Our work reveals key aspects to controlling mitochondrial dynamics in response to low oxygen tension," said Dr. Ronai, associate director of Sanford-Burnham's National Cancer Institute-designated Cancer Center and senior author of the study. "By manipulating mitochondrial dynamics, we can help cells adapt to ischemic conditions in a way that might translate into new treatment options for patients who've experienced a heart attack."

Siah2 is an ubiquitin ligase, meaning its job is to tag other proteins with a molecule called ubiquitin, marking them for destruction. This way, Siah2 controls which proteins are active and which are destroyed in response to . In this study, Dr. Ronai and his team found that one such signal—low oxygen, a condition also known as hypoxia—engages Siah2 in the control mitochondrial fragmentation process by allowing two key regulators (the proteins Drp1 and Fis1) to get together. Their union, however, increases mitochondrial fragmentation, cell death, and cardiac tissue damage under ischemic conditions.

"In a hypoxic environment, increased Siah2 activity takes a protein called AKAP121 out of the picture, freeing up the Drp1-Fis1 complex to shift the balance in favor of mitochondrial fragmentation," explained Hyungsoo Kim, Ph.D., postdoctoral researcher in Dr. Ronai's lab and first author of the study. "This change in mitochondrial structure is accompanied by changes in function that lead to heart under stress, giving us a new understanding of how cells respond to hypoxia and a new target to prevent the damage often seen in ischemic injury."

When the researchers mimicked in cells and mice lacking Siah2, AKAP121 levels increased (keeping a damper on the Drp1-Fis1 relationship), mitochondrial fission was reduced, and fewer heart cells died. Under hypoxic conditions, Siah2-deficient mice fared better than their normal counterparts.

Dr. Ronai credits a collaborative approach for the success in demonstrating both Siah2's role in mitochondrial fragmentation and its physiological importance. Teaming up with the laboratory of Sanford-Burnham's Mark Mercola, Ph.D. helped unravel Siah2's role in cardiovascular function. In addition, contributions by the laboratory of Andrew Dillin, Ph.D. at the Salk Institute for Biological Studies revealed the roles of Siah2 and in the lifespan of C. elegans, a worm model.

Dr. Ronai and his team are now searching for chemical compounds that inhibit Siah2, which they hope can be further developed into new therapies for cardiac damage and cancer.

Provided by Sanford-Burnham Medical Research Institute

5 /5 (2 votes)

Related Stories

How prostate cancer packs a punch

Jul 12, 2010

Some types of prostate tumors are more aggressive and more likely to metastasize than others. Nearly one-third of these aggressive tumors contain a small nest of especially dangerous cells known as neuroendocrine-type cells. ...

Alzheimer's disease linked to mitochondrial damage

Apr 02, 2009

Investigators at Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide—which causes a chemical reaction called S-nitrosylation—mediates ...

New role for the JNK protein

Jul 14, 2010

Put simply, a tumor is the result of out-of-control cell growth. To assure that the cell cycle - the cell's process of duplicating itself to make more cells - goes smoothly, a large network of proteins tells other proteins ...

Recommended for you

Towards renal artery stenosis treatment

12 hours ago

Renal artery stenting to open blockages in the kidney arteries may benefit patients who have historically been excluded from modern clinical trials, according to new recommendations for renal artery stenosis e-published in ...

New technologies help people with heart disease

17 hours ago

People taking part in cardiac rehabilitation exercise programmes are likely to maintain healthy behaviours for longer with text message and web-based support, according to recent research from the University of Auckland.

A novel pathway for prevention of heart attack and stroke

Aug 21, 2014

A recent Finnish study could pave the way for preventing brain and cardiac ischemia induced by atherosclerosis. Finnish researchers have found that the low-expression variant of fatty acid-binding protein 4 (FABP4), which ...

User comments